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TODAY THROMBOSIS and embolism are the commonest causes of death after
a major abdominal operation (Muir, 1968). Since 1960 thrombosis and embolism
have been the leading cause of maternal death in England and Wales (Jeffcoate and
Tindall, 1965). Morrell, Truelove and Barr (1963) confirmed a marked increase in
the decade 1952 to 1961. These findings contrast with the reported incidence in
African races (Lee, Davies and Florentin, 1966). Smith, Dexter and Dammin (1965)
in post-mortem studies in Boston found pulmonary embolism to be the single most
common cause of death. Frieman and his colleagues (1965) also from Boston, found
evidence for old or recent pulmonary emboli in 64 per cent of a group of con-
secutive autopsied patients. Sevitt and Gallagher (1962) also demonstrated a high
incidence of venous thrombosis and pulmonary embolism in those dying after
injury or burning.
During a twelve-month period through 1967-68 twenty patients were seen with
venous thrombosis and its complications; a marked increase in the Department of
Surgery at the Royal Victoria Hospital (Rogers, 1968). One thousand six hundred
and fifty patients were admitted during this period and there were two diagnosed
deaths from pulmonary embolus. In three of eight patients with clinical signs of deep
venous thrombosis, pulmonary emboli complicated management. Six pulmonary
emboli treated were "silent", that is, without signs of peripheral thrombosis
(Table I).
TABLE I
An outline of the clinical features presented by twenty patients with
venous thrombosis studied from a twelve-month period through 1967-68
No. ofpatients
Total number of patients 20
Number of deaths from pulmonary emboli 2
Total number of patients with pulmonary emboli 10
Number of patients with "silent" pulmonary emboli 6
Deep venous thrombi of lower limb 8
Septic pelvic thrombophlebitis with pulmonary embolus I
Superficial venous thrombosis of the lower limbs 4
Subclavian vein thrombosis I
Rational management of any clinical problem in medicine requires an under-
standing of pathogenesis. In venous thrombosis the importance of stasis of the blood
has not been sufficiently emphasised. Therefore, this paper is divided into two
sections; a discussion of factors influencing thrombus formation, and a clinical
study of twenty patients with venous thrombosis and its complications.
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The triad of factors which initiate thrombosis in vivo are stasis of the blood,
physical changes in the vessel wall and alteration in the blood itself (Virchow, 1856).
Although the biochemical stages of coagulation are now established, the precise
initiating mechanisms can still only be expressed in terms of Virchow's triad.
Therefore, treatment of thrombosis has remained nonspecific and aimed at reversal
or prevention of these factors. Recently an important morphological distinction
between arterial and venous thrombosis has influenced therapy (Wessler, 1962).
Traditionally a distinction has been made between clots formed from blood in a test
tube and thrombosis within the vascular tree. Wessler (1962) observed that thrombi
formed in slowly flowing blood in veins have a similar structure to in vitro or post
mortem clots. Histologically these stasis thrombi consist of fibrin and red cells;
whereas arterial thrombi are white and consist mainly of platelets (Mustard et al.,
1962; Wessler, 1962; Poole, French and Cliff, 1963; Rosenburg and Dintenfass,
1964; Gurewich and Thomas, 1965; Salzman, 1965). This morphological differen-
tiation is not absolute but varies as a function of blood velocity (Mustard et al.,
1962; Dintenfass, 1964). It must also be emphasised that the fundamental initiating
event in both arterial and venous thrombosis is formation of a platelet nidus (Poole
and French, 1962); but subsequent thrombus accretion in veins is fibrinous
(Robertson, Moore and Mersereau, 1959; Wessler, 1962; Allison, 1965).
The importance of such a distinction is further clarified by evaluation of factors
initiating thrombosis, and the relation of methods of treatment to those factors.
STASIS OF THE BLOOD
Clinical and experimental evidence has accumulated to support the above
morphological observation that venous thrombosis occurs primarily because of stasis
of the blood (Gibbs, 1951 ; McLachlin and Peterson, 1954; McLachlin, McLachlin,
Jory and Rawling, 1960; Wessler, 1962; Bauer, 1964; Kernohan and Todd, 1966).
However, Martin and Stefanine (1960) and Wessler (1962) have shown that stagna-
tion of the blood is insufficient cause alone and hypercoagulability and/or vesselwall
injury (Mustard et al., 1962) is necessary to initiate thrombus formation. Therefore,
prevention of venous thrombosis should be based on reversal of stasis of the blood
i.e. improvement of venous return, before, during and after illness or operation.
Alteration in the Constituents of the Blood:
(a) The Platelet - In vitro measurement of platelet adhesiveness shows an in-
crease, together with a rise in platelet count, after trauma (Dawbarn, Earlam and
Evans, 1928; Wright, 1942; Owren, 1963; Emmons and Mitchell, 1965). Wright
(1942) initially suggested that this change in adhesiveness might indicate a tendency
to post-operative leg thrombosis. Hirsch and McBride (1965), Owren (1965) and
Bygdeman, Eliasson and Johnston (1966) have confirmed this tendency. Recently
evidence is accumulating that a rise in platelet adhesiveness is not specific to the
post-traumatic state (Mitchell, 1968) nor constantly an indication of a thrombotic
tendency (Pinto, 1968).
Heparin and prothrombin depressants have little effect on platelet aggregation and
adhesion to the vessel wall when given in a dosage conventionally used for treatment
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Poole, 1963; Robb, Jacobson and Jordan, 1963). The search continues for a safe
and effective inhibitor of platelet aggregation. However, when found, the agent is
more likely to be useful in the prevention of arterial thrombosis.
(b) Plasma Coagulation - A hypercoagulable state occasionally arises because of
a disturbance in the dynamic equilibrium between the intrinsic coagulation mech-
anism and the fibrinolytic system (Astrup, 1958 ; Wessler, 1962). A large proportion
of intravascular coagulation syndromes, independent of operation or trauma, have
a neoplasm as their underlying cause (Mosesson, Colman and Sherry, 1968). Con-
sumption coagulopathy is an extreme example of this syndrome in which dis-
seminated microvascular coagulation produces systemic hypofibrinogenaemia and
thrombocytopenia by consumption (Rodriguez-Erdman, 1965; Mosesson, Colman
and Sherry, 1968). At present there is no consistently positive test for the presence
of hypercoagulability (de Takats, 1966; Hume, 1966). Local hypercoagulability or
reduced fibrinolysis (Silver, 1966) may initiate thrombosis in the absence of systemic
changes.
Small amounts of heparin inhibit fibrin clot formation (Poole, 1959; Berman,
1963 ; Salzman, 1965), and this natural anticoagulant is at present the drug of choice
for treating venous thrombosis and pulmonary embolism. Once the coagulation
mechanisms of the blood are enzymically blocked by heparin the lytic effect of the
plasma comes into play (Jorpes, 1962) possibly catalysed by the action of heparin
(Hajjar and Moser, 1962).
The marked reduction by heparin of the incidence of fatal pulmonary embolism,
recurrent venous thrombosis, chronic venous insufficiency and severity of inflam-
matory thrombophlebitis, initially demonstrated by Bauer (Jorpes, 1962) has been
confirmed many times (Murray, 1947; Cosgrieff, 1950; Fuller, Robertson and
Smithwick, 1960; Stamm, quoted by Jorpes, 1962).
There is some evidence that prothrombin depressants are useful in the post-
operative prevention of pulmonary embolus (Sevitt, 1962; Skinner and Salzman,
1967). However, a large body of clinical experimental evidence demonstrates the
superiority of heparin in the treatment of venous thrombosis and pulmonary
embolism (Warren and Belko, 1957; Carey and Williams, 1960; Fuller, Robertson
and Smithwick, 1960; Engelburg, 1962; Jorpes, 1962; Diamond, 1964; Laufman,
1964; Ker;nohan and Todd, 1966; Reeve, Hunt and Argall, 1966).
(c) Blood Viscosity - Most coagulation studies are carried out in static in vitro
conditions, but thrombosis occurs in flowing blood. Factors of internal friction
between the constituents of blood and the vessel wall must, therefore, be considered
in the mechanism of thrombosis. Applied to biology, the science of flow and defor-
mation of matter, is labelled biorheology.
With slowing of microcirculatory blood flow, red blood cells tend to aggregate
in rouleaux and lie in the axial stream of the vessel. The smaller white cells and
platelets are displaced towards the vessel wall (de Takats, 1966). The platelets
situated near the vessel wall are in a zone of higher shear rate which increases
platelet adhesiveness and aggregation may occur (Dintenfass, 1968). The plasma
protein content of this zone is especially important in the microcirculation as shear
rates are very high in the narrow space between cell and vessel wall (Wells, 1964;
Litwin, 1965). Abnormal plasma proteins are found at times in conditions of chronic
78intravascular coagulation (Mosesson, Colman and Sherry, 1968) and may cause
thrombosis by increasing plasma viscosity.
Dintenfass (1968) has demonstrated an in vitro disproportionate increase in blood
viscosity at low rates of shear in patients with venous thrombosis and coronary
occlusion when compared with normals. He has also confirmed in his rheological
studies the importance of slowing of the blood in the initiation of coagulation and
thrombosis.
Part 2: CLINICAL STUDY
Fourteen of the twenty patients studied were female and the mean age was fifty-
five years. Clinical deep venous thrombosis in the lower limbs presented as early
as two days and as late as forty-four days after operation. Pulmonary emboli
occurred at a mean time of eleven days after operation. The majority had intro-
abdominal surgery before developing venous thrombosis but many other aetiological
factors were present (Table II).
TABLE II
Causal factors in venous thrombosis and pulmonary embolism
No. ofpatients
Post-operative
Upper gastrointestinal 5
Lower gastrointestinal 2
Urological 2
Thoracotomy 3
Mastectomy I
Malignant disease 4
Obesity 9
Venous disease of the lower limb
Previous deep venous thrombosis 2
Varicose veins 5
Prolonged immobilization 20 days 4
Cardiac disease 2
Sepsis
Pelvic post-partum I
Wound 4
Septicaemia I
Respiratory insufficiency 4
Idiopathic 3
Four patients with deep venous thrombosis had haematological investigations in
an attempt to establish the presence of a hypercoagulable state (Table III). No
patients with a consumption coagulopathy were revealed, nor was any reliable
pattern of results to indicate an increased tendency for thrombosis established. On
one occasion a patient with no obvious cause of thrombosis (patient No. 1 - Table
III) demonstrated increased platelet adhesiveness with high levels of fact VIII and
fibrinogen in the absence of increased fibrinolysis which could be interpreted as a
hypercoagulable state. However, subsequent haematological investigations were near
normal.
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Haematological investigations carried out in 4 patients with deep venous
thrombosis of the lower limbs (D.V.T.)
Factor Partial Heparin
Platelet Platelet Fibrinogen Vill thrombo- tolerance test
Cause D.V.T. count adhesiveness (mg%) level plastin (% ofcontrol
(/cu.mm.) (%) (%) time (secs) response)
Normal values 200-300,000 20-35 250-400 100 29-45 100
1.
Idiopathic 250,000 Increased 320 348 36
(50)
2.
Small bowel 550,000 40 175 270 45 65
malabsorption 399,000 - 230 265 40 80
3.
Idiopathic 148,000 50 185 100 40 100
4.
Post
prostatectomy 175,000 30 180 120 32 80
(In the idiopathic case platelet factor III, platelet aggregation response to adenosine di-
phosphate and the prothrombin level were normal. The euglobulin was slightly reduced and
the thrombin titre was 1.64 against a control of 1.32.)
An additional patient with pancreatic absesses and duodenal fistula developed
spontaneous bleeding after resolution of his deep venous thrombosis and pulmonary
embolism. Investigations demonstrated excess fibrinolysis causing bleeding through
the duodenal fistula which was controlled eventually with epsilon-amino-caproic
acid. This patient illustrated a disturbance of the delicate balance between coagula-
tion and fibrinolysis. Initially heparin was required to reverse hypercoagulability
and then epsilon-amino-caproic acid to counteract excess fibrinolysis.
DIAGNOsIS
Eight patients were treated for clinical evidence of unilateral deep venous throm-
bosis of the lower limbs. In all cases there was calf tenderness, oedema causing
increase in diameter of the limb, a "doughy feel" of the calf muscles and mild
fever and tachycardia. The mild fever and tachycardia constantly developed just
after the diagnosis was made. Six of the eight patients had a positive Homan's sign.
In five patients oedema of the thigh and tenderness over the femoral vein indicated
proximal propagation of thrombus into the ileo-femoral venous system. Ten patients
were treated for a clinical diagnosis of pulmonary embolus. The clinical signs are
shown in Table IV.
Particular clinical signs divide sufferers into two basic groups. Those with mild
or moderate clinical response to emboli and those with major or massive emboli.
It is often difficult to distinguish the manifestations of lesser emboli from the
features of post-operative sputum retention and its sequelae. Pulmonary emboli are
clinically different because of acute onset with pleuritic pain and splinting of the
chest wall and tachypnoea to a disproportionately greater extent than other signs
(Berger, Ryan and Sidd, 1968). Haemoptysis to confirm the diagnosis was present
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Symptoms and signs of 10 patients with pulmonary embolism
NumberofPatients
Chest pain
Pleuritic 6
Retrosternal 1
None 3
Haemoptysis 3
Cough 3
Tachypnoea out of proportion to other signs 9
Pyrexia 6
Pleural friction rub 2
Peripheral circulatory failure 4
Right heart failure 3
in only three cases in this small series (Table IV). Generally this group of patients
do not show symptoms or signs of peripheral vasoconstriction because of reduced
cardiac output.
Two of the four patients with major pulmonary embolus died within twenty
minutes of lodgement of the embolus. In one patient a diagnosis of cerebral
vascular accident was made before death five days after a nephrectomy for pyone-
phrosis. At post mortem a massive pulmonary embolus was found and the presence
of clinically undetected venous thromboses in the lower limbs confirmed. This
form of presentation is unusual but well recognised (Levine, 1968). The other
patient had been treated with heparin for a post-abdomino-perineal deep venous
thrombosis. The heparin was stopped before full mobilization of the patient.
The other two patients with large emboli showed evidence of reduced cardiac
output. One patient with septic emboli to the lung had no pain but fainted when
sat upright. The other patient had severe retrosternal chest pain, dyspnoea and signs
of poor cardiac output with hypotension and peripheral cyanosis. The electro-
cardiogram showed right heart strain and there was clinical evidence of right heart
failure. This common type of presentation must be distinguished from myocardial
infarction. Also occasional clinical confusion may arise in the differential diagnosis
of concealed post-operative haemorrhage (Reeve, 1966) and septicaemic shock
(Berger, Ryan and Sidd, 1968).
Specific changes in the chest x-ray did not aid the diagnosis of pulmonary em-
bolism in this series. Elevation of the diaphragm and basal collapse were common
findings. In two cases the chest x-ray was normal pre-operatively and after
pulmonary embolus.
In eight patients a lung scan was performed after intravenous injection of
istopically labelled macroaggregated human serum albumin. The small radioactive
aggregates become temporarily lodged in pulmonary capillaries. An area of low
radioactive count indicates an area of low pulmonary blood flow. This test is safer
than angiography but does not share its specificity in the diagnosis of pulmonary
embolism (Sabiston, Durham and Wagner, 1965). The findings helped to reinforce
the clinical diagnosis in this series. The incidence of false negative diagnosis is
virtually nil (Berger, Ryan and Sidd, 1968).
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Prevention
Thromboembolism is primarily a disease of hospitalization and prevention should
be the aim of physician and surgeon. Pre-operative chest x-ray and electrocardio-
gram would aid early diagnosis by comparison with such investigations repeated
during a possible embolic episode (Henderson, 1964). The lower limbs should be
examined each day of a patient's admission.
Continued pre-operative exercise and early post-operative movement and ambula-
tion is the basis of the general aim to prevent venous stasis. In patients with post-
operative complications and prolonged or restrictive illness early mobilization is
difficult and prothrombin depressants have been used to prevent venous thrombosis.
This must not absolve one from a responsibility to restore active full muscle move-
ment and thereby promote venous return. Keely and Schairer (1964) report only
two deaths from a total of five pulmonary emboli after four thousand four hundred
and forty-eight operations while applying this basic aim.
The use of one way stretch cotton elastic bandages to promote venous return
(Meyerowitz and Nelson, 1965) is advisable throughout the hospital stay for all
patients with varicose veins, previous venous thrombosis, cardiac and respiratory
disease and obesity as all are vulnerable to venous thrombosis (Barker, 1959;
Reeve, Hunt and Argall, 1966). Pre-operative heart and lung function should be
supported and improved (Allison, 1965; Kernohan and Todd, 1966; Reeve, Hunt
and Argall, 1966).
There is good evidence that most deep venous thromboses commence during
operation (Pinto, 1968). Venous return is improved by elevation of the legs (Wright
and Osborn, 1952; McLachlin, McLachlin, Jory and Rawling, 1960). A bolster
under the tendo Achilles will both elevate the legs and relieve compression of veins,
through calf muscles, flaccid under anaesthesia.
Certain dangerous situations may arise when patients are got out of bed early
after an operation. Homans called attention to the danger of compression behind
the knees by the edge of a chair when sitting for long periods. An increased
incidence of thrombo-embolism has been noted in normal individuals after pro-
longed sitting in underground air-raid shelters (Simpson, 1940), in front of television
(Naide, 1957) and in cars on long journeys (Keeley and Schairer, 1964). Post-
operatively patients are directed to walk while standing and if they must stop, to sit
or lie down with the legs elevated.
Treatment of Deep Venous Thrombosis
Suspicion as well as confirmation of the diagnosis is an indication for treatment
of thrombophlebitis. The foot of the bed is elevated and one-way stretch cotton
elastic bandages are applied to both legs from toes to upper thighs. As well as
promoting the venous return the bandages act as an accessory muscle pump and
prevent oedema. When the thrombosis occurs in a limb already oedematous as a
result of previous thrombosis, diuretics are used to help mobilise the fluid, Any
aetiological factor, such as cardiac failure, is treated. Analgesics and sedatives are
given as required, but usually heparin rapidly relieves the pain. Antibiotics are
used only for those patients developing pulmonary infarction after pulmonary
embolism, unless there is some other compelling indication.
82Each patient is given a loading dose of 10,000 units of intravenous heparin
followed by a continuous intravenous infusion of heparin in a standard dosage of
30,000 units in each twenty-our hours. This is delivered per each twelve-hour period
in 500 ml. of a 5 per cent solution of dextrose in water (Reeve, Hunt and Argall,
1966). This method was chosen as being superior to intermittent four-hourly
intravenous injections through an indwelling needle, which results in adequate
prevention of coagulation for only part of this interval (Biggs and McFarlane,
1957). The regularity of this method depends on the workload of the house staff.
Lack of punctuality leads to lack of protection. Local problems, such as phlebitis,
are rare with a continuous infusion of heparin and did not occur in this series. The
dose of heparin is so calculated that if by mischance the whole amount is rapidly
infused, no problems should result. Serial subcutaneous injections produce a sus-
tained level of heparin in the blood which makes rapid neutralization by protamine
sulphate difficult (Gurewich, Thomas and Stuart, 1967). Most serious haemorrhagic
complications reported have been in association with the subcutaneous or intra-
muscular routes (Knight and Valentine, 1962; Morrison and Wurzel, 1964;
Amador, 1965).
Lee and White "coagulation times" accurately indicate heparin levels in the blood
(de Takats, 1961), and can be used to govern individual heparin requirements such
that spontaneous bleeding is rare (Reeve, Hunt and Argall, 1966; Gurewich,
Thomas and Stuart, 1967). Heparin dosage is varied to produce a coagulation time
of from two to three times normal (16 to 24 minutes). Some patients appear
sensitive and require less heparin while some are resistant and require more (Dew-
hurst and Poller, 1965; Reeve, Hunt and Argall, 1966). Both groups of patients
are more prone to complications (Reeve, Hunt and Argall, 1966). Two of the three
patients in this series who were heparin resistant had no obvious cause of
thrombosis.
Eight of the nine patients with unilateral deep venous thrombosis studies were
treated with a continuous intravenous infusion of heparin. The ninth patient treated
by serial subcutaneous heparin developed a pulmonary embolus during treatment
and was left with residual chronic deep venous insufficiency. Ten courses of
TABLE V
Results of treatmnent of 14 patients with venouis thromnbosis and pulmonary
embolism with a continuous intravenous infusion of heparin
Com-
No. Chronic Pulmonary plication
of Recur- venous hyper- of heparin
patients rence insuffiency tension therapy Deaths
Deep venous
thrombosis of
the lower limb 5 2 0 - 0 0
Thrombosis
and embolism 3 1 0 0 0 1
"Silent" pul-
monary embolism 6 0 - 0 0 0
83heparin by continuous infusion were given, as there were two recurrent deep venous
thromboses treated (Table V). The heparin therapy produced early resolution of the
clinical features of thrombophlebitis, particularly the pain, tenderness and resultant
anxiety. One patient developed a fatal pulmonary embolus after stopping heparin
therapy and before she was fully mobilised.
Bruising of the buttocks is usually the first sign of heparin overdosage, preceding
haematuria (Reeve, Hunt and Argall, 1966), and the buttocks should be examined
every morning and evening while patients are receiving heparin, just as are the legs.
However, such signs are considered along with the coagulation time in deciding on
continuing dosage.
The patient is allowed to walk with legs firmly bandaged, carrying his infusion
apparatus, once his signs and symptoms are going. The heparin dosage is stopped
forty-eight hours after no tenderness can be elicited in the calf or along the line of
the femoral and iliac veins provided that the patient has been ambulant (Bauer,
1964). If there is no recurrence, he is discharged from the hospital four to five days
after stopping therapy. The usual period of treatment is ten days.
The patients are sent home with their legs still bandaged. After about one month
one way stretch heel enclosed cotton elastic stockings are worn for at least six
months after discharge from hospital. Patients should continue to keep the foot of
the bed raised at home, and should avoid the prolonged dependency of their legs
associated with extensive car travel. Reduction of weight is advised for the obese.
Patients are informed about their problem, and their medical attendants are
properly notified, so that early care can be instituted if a recurrence occurs.
The most important measure in the long term is the restoration and maintenance
of a normal venous return. This is primarly based on the continuance of adequate
exercise. Prothrombin depressants are unnecessary and probably ineffective (Moses-
son, Colman and Sherry, 1968) in long-term management of venous thrombosis
(Reeve, Hune and Argall, 1966). In patients with consumption coagulopathy heparin
is the only long-term effective treatment until a common underlying neoplasm is
eradicated (Mosesson, Colman and Sherry, 1968).
Four patients in this series were treated for superficial thrombophlebitis alone.
Three had varicose veins, one occurred postoperatively. In each case, conservative
therapy was planned, the foot of the bed was elevated, local and systemic anti-
inflammatory agents were used and the legs were bandaged. In one patient a very
severe inflammatory reaction with vesication initiated the use of heparin and anti-
biotics were given for secondary infection.
Treatment of Pulmonary Embolism
Two of the ten patients in this group died within minutes of their embolus. They
were not given heparin. Heparin is the only form of therapy in such a situation
which has any success (Kernohan and Todd, 1966). Fatal pulmonary embolism is
uncommon once a large dose of heparin has been given intravenously (Barritt and
Jordan, 1960). Six patients were treated by heparin infusion intravenously by the
method already described (Table V). In all cases there was rapid relief of pain and
resolution of physical signs supporting the theory that heparin inhibits pulmonary
vasoconstrictive and bronchoconstrictive reflex phenomena associated with pul-
monary embolus (Thomas, 1965).
84The foot of the bed is elevated and bandages applied to the legs whether deep
venous thrombosis is clinically evident or not. Treatment is continued for ten or
twelve days. Recent angiographic studies in man have shown that resolution of
pulmonary emboli may take place within this period (Fred and others, 1966). Again
full activity is established before stopping heparin therapy. Underlying heart disease
is common (Sasahara and others, 1966), and must be adequately treated.
CONCLUSIONS
In contrast to arterial thrombosis, venous thrombosis occurs primarily because of
slowing of the blood flow. Hypercoagulability and/or vessel wall injury are, how-
ever, necessary to initiate thrombosis in veins.
Prevention of venous thrombosis should be based on reversal of stasis of the
blood, that is, improvement of venous return, before, during and after illness or
operation.
At present heparin is the anticoagulant of choice for the treatment of venous
thrombosis and pulmonary embolism.
The principals of conservative management and results of treatment of venous
thrombosis and pulmonary embolism using a continuous intravenous infusion of
heparin are presented.
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